Orthofix reports $40.5M loss & more: 7 device company notes

Written by Eric Oliver | October 30, 2019 | Print  | Email

Here are seven key notes on spine and orthopedic device companies: 

In the third quarter of 2019, Orthofix reported a net loss of $40.5 million, a 3,244 percent decrease year over year, and announced that Jon Serbousek would serve as the company's CEO. Read more.

Johnson & Johnson Medical Shanghai entered into a co-marketing agreement and research and development agreement with the orthopedic robotics market leader in China, Tinavi. 

A California court dismissed a portion of a labor lawsuit against Zimmer Biomet and its affiliates because the person bringing the case was exempt from federal and California labor laws.  

Several plants that sterilize essential surgical tools with ethylene oxide have shut down, leaving hospitals vulnerable to supply shortages.

The United States Patent and Trademark Office granted Spineway a patent for its minimally invasive surgery technology Mont-Blanc MIS.

Kenai Spine is using new spinal implants developed by Nanovis for spinal fusion procedures in Alaska.

Cleveland Clinic released its list of top 10 medical innovations for 2020, including three related to orthopedics and spine.

More articles on devices: 
Orthofix reports $40.5M net loss in Q3, Jon Serbousek to become CEO: 5 details
New York orthopedic center to introduce robot for total knee replacements

California court tosses portion of labor suit against Zimmer Biomet — 4 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.